GPhA seeks current biosimilars language struck from US reform bills
This article was originally published in Scrip
Executive Summary
The US generics group GPhA is asking President Barack Obama to urge congressional leaders to strike biosimilars language from pending healthcare reform legislation unless the proposed 12-year exclusivity term for innovative biologicals is reduced.